BZPEERReading, trust and collaboration for research
Menu

Discover

GraphFollow connections around a paper, topic or saved view.

Workspaces

HomePick up where your research flow left off.InboxHandle requests, replies and notifications from one place.CollectionsCurate reading lists, evidence sets and shareable dossiers.ResearchSee your private provenance graph, trail and imports.CollaborationMove from discovery into focused discussion rooms.PublishDraft, preview and publish full-text research articles.

Network

ExpertsFind specialists worth following or asking for help.CommunitiesJoin research circles organized around shared work.PartnersSee external organizations active around the same topics.

Opportunities

ListingsBrowse roles, calls and collaborations with clearer fit signals.

Account

Log inReturn to your reading and collaboration workspace.Create accountStart saving work, following people and joining teams.
Log inCreate account

Researcher profile

Gaurav Pachpute

Gaurav Pachpute contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate
math.OCOther Quantitative BiologyQuantitative Methods

Trust snapshot

Quick read

Trust 13 - UnverifiedVerification L1Unclaimed author
2works
0followers
3topics
2close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

2 published item(s)

preprint2011arXiv

Free Final-Time Optimal Control for HIV Viral Dynamics

In this paper, we examine a well-established model for HIV wild-type infection. The algorithm for steepest descent method for fixed final-time is stated and a modified method for free final-time is presented. The first type of cost functional considered, seeks to minimize the total time of therapy. An easy implementation for this problem suggests that it can be effective in the early stages of treatment as well as for individual-based studies, due to the "hit first and hit hard" nature of optimal control. An LQR based cost functional is also presented and the solution is found using steepest descent method. It suggests that the optimal therapy must remain high until the patient shows signs of recovery after which, the therapy gradually decreases. This is in line with the biomedical philosophy. Solution to a modified problem which includes a weight for total time is approximated using the modified algorithm. It shows a considerable drop in the total period. We conclude that, a decreased and optimized therapy period can help us increase efficiency as well as the turnover rate for patient care.

0 citations0 reviewsNo code linkedOpen access
preprint2011arXiv

Optimal Therapy of Hepatitis C Dynamics and Sampling Based Analysis

We examine two models for hepatitis C viral (HCV) dynamics, one for monotherapy with interferon (IFN) and the other for combination therapy with IFN and ribavirin. Optimal therapy for both the models is determined using the steepest gradient method, by defining an objective functional which minimizes the infected hepatocyte levels, virion population and the side-effects of the drug(s). The optimal therapy for both the models shows an initial period of high efficacy, followed by a gradual decline. The period of high efficacy coincides with a significant decrease in the infected hepatocyte levels as well as viral load, whereas the efficacy drops after liver regeneration through restored hepatocyte levels. The period of high efficacy is not altered significantly when the cost coefficients are varied, as long as the side effects are relatively small. This suggests a higher dependence of the optimal therapy on the model parameters in case of drugs with minimal side effects. We use the Latin hypercube sampling technique to randomly generate a large number of patient scenarios (i.e, model parameter sets) and study the dynamics of each set under the optimal therapy already determined. Results show an increase in the percentage of responders (as indicated by drop in viral load below detection levels) in case of combination therapy as compared to monotherapy. Statistical tests performed to study the correlations between sample parameters and the time required for the viral load to fall below detection level, show a strong monotonic correlation with the death rate of infected hepatocytes, identifying it to be an important factor in deciding individual drug regimens.

0 citations0 reviewsNo code linkedOpen access